Prelude Capital Management’s Protolabs PRLB Stock Holding History

Prelude Capital Management’s Portfolio PRLB Stock Details PRLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$232K	Sell	2,846 -1,060	-27%	-$74.6K	0.02%	917
2026 Q1	$223K	Sell	3,906 -1,436	-27%	-$83.3K	0.02%	859
2025 Q4	$270K	Buy	5,342 +60	+1%	+$3.07K	0.02%	849
2025 Q3	$264K	Buy	+5,282	New	+$242K	0.02%	790
2024 Q4	–	Sell	-13,241	Closed	-$389K	–	1484
2024 Q3	$389K	Buy	13,241 +6,611	+100%	+$202K	0.02%	732
2024 Q2	$205K	Sell	6,630 -4,154	-39%	-$132K	0.01%	997
2024 Q1	$386K	Sell	10,784 -5,107	-32%	-$184K	0.02%	762
2023 Q4	$619K	Buy	15,891 +7,045	+80%	+$228K	0.04%	429
2023 Q3	$234K	Buy	8,846 +1,742	+25%	+$52.6K	0.02%	813
2023 Q2	$248K	Buy	+7,104	New	+$226K	0.02%	739

Other funds holding PRLB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Prelude Capital Management's PRLB Position: Q2 2026 in Review

Prelude Capital Management reduced its Protolabs (PRLB) stake by 27% in Q2 2026, selling an estimated $74.6K and leaving 2,846 shares worth $232K. The position accounts for 0.02% of the portfolio, ranked #917.

Prelude Capital Management first reported a position in PRLB in Q2 2023 and has held it in 10 quarters since. The position peaked at $619K in Q4 2023. 277 funds tracked by Wall St. Rank hold PRLB as of Q2 2026.

Prelude Capital Management held 2,846 shares of Protolabs worth $232K as of Q2 2026.
Prelude Capital Management sold 1,060 Protolabs shares in Q2 2026, an estimated $74.6K.
Protolabs made up 0.02% of Prelude Capital Management's portfolio in Q2 2026, its #917 holding.
Prelude Capital Management first reported a position in Protolabs in Q2 2023 and has held it in 10 quarters since.
Prelude Capital Management's Protolabs position peaked at $619K in Q4 2023.
277 funds tracked by Wall St. Rank held Protolabs as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.